Literature DB >> 16615286

Findings of chest radiograph and spiral computed tomography in Swyer-James syndrome.

He-shui Shi1, Fan Yang, Ping Han, Jin-long Zheng, Gan-sheng Feng, Yong-hua Liu, Zhi-liang Tian, Gang Liu.   

Abstract

OBJECTIVE: To evaluate the value of X-ray and spiral computed tomography (SCT) in the diagnosis of Swyer-James syndrome (SJS).
METHODS: A total of 28 patients, 12 males and 16 females, were studied retrospectively. Ages ranged from 11 to 57 years, the mean age was 32 years. All patients underwent inspiratory chest X-ray films, 5 with expiratory chest films and 1 with bronchogram. Furthermore, inspiratory and expiratory SCT scans were performed. The SCT findings were analyzed and compared with X-ray films.
RESULTS: SCT demonstrated 56 lobes with hyperlucency and diminished vascularity. The size of 51 lobes were smaller and 5 were normal. X-ray films showed that hyperlucency was only in 29 lobes, in which 19 lobes were small-sized and the other 10 lobes normal. There were 56 lobes with air-trapping on expiratory SCT scans, but only 5 lobes with air-trapping on expiratory X-ray films. Bronchogram in 1 case demonstrated bronchiectasis and bronchiolitis obliterans. SCT showed 24 patients with bronchiectasis, 9 patients with tuberculosis, 10 patients with bronchiolitis, and 2 with segmental collapse.
CONCLUSION: SCT scan is superior to chest radiography in the diagnosis and differential diagnosis of SJS.

Entities:  

Mesh:

Year:  2006        PMID: 16615286

Source DB:  PubMed          Journal:  Chin Med Sci J        ISSN: 1001-9294


  2 in total

1.  Adult diagnosis of Swyer-James-Macleod syndrome.

Authors:  Onur Tutar; Deniz Esin Tekcan; Cesur Samanci; Ahmet Bas
Journal:  BMJ Case Rep       Date:  2012-12-10

Review 2.  Role of Chest Imaging in Viral Lung Diseases.

Authors:  Diletta Cozzi; Eleonora Bicci; Alessandra Bindi; Edoardo Cavigli; Ginevra Danti; Michele Galluzzo; Vincenza Granata; Silvia Pradella; Margherita Trinci; Vittorio Miele
Journal:  Int J Environ Res Public Health       Date:  2021-06-14       Impact factor: 3.390

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.